Comparative research on (99m)Tc-Rituximab and (99m)Tc-sulfur colloid in sentinel lymph node imaging of breast cancer

BACKGROUND: (99m)Tc-Rituximab is a new specific radiopharmaceutical that binds to the CD20 receptor which is highly expressed on the surface of B cells. We conducted a study in which (99m)Tc-Rituximab was compared with filtered (99m)Tc-sulfur colloid (fTcSC) for sentinel lymph node (SLN) detection i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing-Jie, Zhang, Wan-Chun, An, Cai-Xia, Li, Xiao-Min, Ma, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794795/
https://www.ncbi.nlm.nih.gov/pubmed/31615471
http://dx.doi.org/10.1186/s12885-019-6197-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794795/
https://www.ncbi.nlm.nih.gov/pubmed/31615471
http://dx.doi.org/10.1186/s12885-019-6197-9

Ejemplares similares